Download Free Medical Familial Cancer Risk Assessment: Breast and Ovarian Cancer PowerPoint Presentation

Familial Cancer Risk Assessment: Breast and Ovarian Cancer PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on cancer titled "Familial Cancer Risk Assessment: Breast and Ovarian Cancer" to know about the hereditary breast and ovarian cancer, genetic counseling and testing for hereditary breast and/or ovarian cancer, cancer family history, screening for hereditary breast/ovarian CA in the primary care setting, and when and how to refer patients for genetic services.

Tags : Cancer, Risk, Assessment, Breast, Ovarian Cancer, hereditary, genetic counseling, testing, screening, primary care

Published on : May 05, 2021 | Views : 1050 | Downloads : 3

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Familial Cancer Risk Assessment: Breast and Ovarian Cancer Genetics and Primary Care
Slide 2-

Case 1: Ruth Ruth, a 35 year old Jewish woman, comes for a family planning visit. You inquire about family health history and find out the following information: Maternal family history is negative for cancer Paternal family history is significant for: Paternal aunt with ovarian cancer age at 55 Paternal grandmother with breast cancer age 42 Ruth has no other risk factors or pertinent family history
Slide 3-

Case 2: Alison Alison is a 40 year old Caucasian (non-Jewish) patient who asks you for information about the “breast cancer gene test”. She states she wants this test. You ask about her family history: Mother with breast cancer - age 58 Maternal aunt with breast cancer – age 65 Paternal grandmother with breast cancer – age 79 Alison has no other risk factors for breast cancer She feels that with her family history, breast cancer is inevitable
Slide 4-

Outline Hereditary breast and ovarian cancer Genetic counseling and testing for hereditary breast and/or ovarian cancer Cancer family history – a primary tool Screening for hereditary breast/ovarian CA in the primary care setting When and how to refer patients for genetic services
Slide 5-

Cancer Etiology: ~5-10% of cases have a strong hereditary component ~15-20% are “familial”/multifactorial ~70-75% are thought to be sporadic
Slide 6-

Hereditary Breast/Ovarian CA Occurs in multiple generations Younger ages of onset (often <50) Bilateral cancer or multiple primaries common Family history of unique tumor combinations e.g. sarcoma, breast, brain in same family e.g. male breast cancer, ovarian/breast e.g. breast, thyroid, uterine cancer
Slide 7-

ppt slide no 7 content not found
Slide 8-

Hereditary Breast and Ovarian CA (HBOC) 5-10% of all cases of breast and ovarian cancer About 70 to 85% of HBOC cases are caused by mutations in either the BRCA1 or BRCA2 gene Genetic testing for BRCA1 and BRCA2 gene mutations is available to women with family history meeting “hereditary breast cancer” criteria
Slide 9-

Each cell has two copies of BRCA1 and BRCA2 BRCA2 BRCA1
Slide 10-

BRCA1/2 Mutation Incidence 1 in 800 women in the general population 5-10% of all women with breast CA ~18% of women with breast CA <50 and one close relative with breast CA <50 2% of all women of Ashkenazi Jewish ancestry
Slide 11-

BRCA1/2 Mutations: Cancer Risks BRCA1 BRCA2 Breast cancer to age 80 50-85% 50-85% Ovarian cancer to age 80 20-60% up to 27% Male breast cancer Slight incr. ~6% Prostate cancer Slight incr. Slight incr. Pancreatic cancer No incr. 1.5-5% Melanoma No incr. Slight incr. Daly MD: NCCN 2002 genetic/familial high-risk assessment clinical practice guidelines in oncology.
Slide 12-

Risk-Based Management High/Genetic Risk: BSE monthly starting at age 18 CBE once or twice a year starting age 25 Mammogram once a year starting at age 25 Ovarian surveillance if BRCA1 or 2 mutation positive or family history of ovarian cancer Pelvic exam, trans-vaginal ultrasound, +/- CA-125 once or twice a year; age 25-35 Options: Chemoprevention or prophylactic surgery
Slide 13-

Treatment Options: BRCA1/2 Carriers Chemoprevention Tamoxifen reduces risk in BRCA2 carriers, (still questionable in BRCA1 carriers) Prophylactic bilateral mastectomy ~90% reduction in breast CA risk Prophylactic bilateral oophorectomy ~up to 95% reduction in ovarian CA risk ~50% reduction in breast CA risk
Slide 14-

Other Hereditary Breast Cancer Syndromes Cowden Syndrome – <1% of all BrCA Facial/buccal lesions, GI hamartomas Thyroid, endometrial lesions or CA, macrocephaly Li-Fraumeni – <1% of all BrCA Early-onset sarcoma, leukemia, brain CA Adrenocortical CA, others Peutz-Jeghers - <1% of all BrCA Childhood GI hamartomas, GI CA Pigmentation of lips, buccal mucosa, hands/feet
Slide 15-

ppt slide no 15 content not found
Slide 16-

Cancer Genetic Counseling Full pedigree analysis and risk assessment Discussion of: Personal risks of cancer based on family history Risks of genetic syndrome in the family Appropriate genetic testing and chances of mutation Full informed consent prior to genetic testing Personalized, risk-based screening and prevention options Support resources
Slide 17-

Ethical Issues: Genetic Testing Confidentiality/Privacy Preserve other family members’ confidentiality when documenting family history Potential insurance, employment, social discrimination Sharing information with at-risk relatives What if client refuses? Positive results on one family member suggest risk in others without their consent
Slide 18-

BRCA1/2 and Other Genetic Testing Affected family member should be tested first, when possible If no mutation found (or “uncertain variant”): testing others not warranted If mutation identified, unaffected relatives can be offered testing for that specific mutation - after genetic counseling and informed consent
Slide 19-

What can YOU do?
Slide 20-

Goal: Classification Who needs what? Family Hx Assessment Personalized prevention recommendations Referral for genetic evaluation with personalized prevention recommendations Standard prevention recommendations Intervention Average Moderate (“Familial”) High/Genetic Risk Classification
Slide 21-

Screening for “Familial Cancer” Help your clients collect appropriate Family History Details: Type of primary cancer(s) in each relative Age of disease onset in each relative Cancer status in 1st and 2nd degree relatives Cancer status in both sides of the family Ethnic background on both sides Other medical findings – benign tumors, etc.
Slide 22-

ppt slide no 22 content not found
Slide 23-

Gail Model Calculates 5 yr and lifetime risk (to 90 yrs) of breast cancer based on multiple criteria Limitations: age of onset, 2nd degree relatives, paternal history, ovarian cancer, ethnicity not included in risk analysis http://bcra.nci.nih.gov/brc/start.htm Gail MH: J Natl Cancer Inst (1989); 81; 24; 1979-1886.
Slide 24-

Claus Model Calculates risk of breast CA to age 80 based on: Age of onset of breast cancer in 1st and 2nd degree relatives, including paternal Limitations: May underestimate risk in families with 3 or more affected members; ethnicity not included Claus EB et al. Cancer 73:643-651 (1994)
Slide 25-

Myriad Risk Tables Identifies the chance of detecting a BRCA1 or BRCA2 mutation in women with a family history of early-onset breast and/or breast and ovarian cancer Limitations: breast cancer>50 yrs not included; clinical data not validated www.myriad.com Genetics referral appropriate for women with significant risk of mutation
Slide 26-

Breast/Ovarian Cancer Risk Assessment Likelihood of developing breast cancer: Gail model Claus model Likelihood of having a BRCA1 or 2 mutation Myriad risk tables BRCAPRO, Couch, Shattuck-Eidens, CAGene Likelihood of other breast cancer syndrome Pedigree analysis
Slide 27-

Case 1: Ruth Ruth, a 35 year old Jewish woman, comes for a family planning visit. You inquire about family health history and find out the following information: Maternal family history is negative for cancer Paternal family history is significant for: Paternal aunt with ovarian cancer age at 55 Paternal grandmother with breast cancer age 42 Ruth has no other risk factors or pertinent family history. Her first menses was at age 12.
Slide 28-

Case 1: Pedigree Key -Breast CA -Ovarian CA Dx 55 d. 56 Dx 42 82 yrs Ruth 35 Russian Jewish Polish Jewish 37 28 60 58
Slide 29-

Case 1: Risk Assessment Gail Model: 0.3% five year risk. 11.3% lifetime risk Claus Model: No category for 1 breast CA, 1 ovarian CA in second degree relatives Lifetime risk of 10.4% based on affected paternal grandmother Limitations in each model
Slide 30-

Case 1: BRCA1/2 Risks Myriad Table: 28.6% risk of mutation in patient 41.3% risk of mutation in grandmother Referral for Cancer Genetic Counseling is appropriate For cancer risk assessment and discussion of genetic testing for BRCA1/2
Slide 31-

Consider cancer genetic counseling referral if: Myriad table indicates significant risk for BRCA1/2 mutation Family medical history is suspicious for a hereditary cancer syndrome Client has extreme anxiety about the cancer family history Client has questions beyond the scope of your practice
Slide 32-

“High/Genetic Risk” Indications for referral Two 1st degree, or one 1st and one 2nd degree relative in the same lineage with breast cancer <50 yrs 3 or more family members (1st or 2nd degree) with breast cancer, same lineage, any age Male with breast CA + breast or ovarian CA in a relative
Slide 33-

“High/Genetic Risk” Indications for referral (cont.) Patient or 1st degree relative with breast CA <40 yrs, with or without family history Two or more cases of ovarian CA, same lineage Ashkenazi Jewish ancestry and any family history of breast <50 or ovarian cancer, any age Both breast and ovarian CA, same lineage
Slide 34-

Case 2: Alison Alison is a 40 year old Caucasian (non-Jewish) patient who asks you for information about the “breast cancer gene test”. She states she wants this test. You ask her about her family history: Mother with breast cancer - age 58 Maternal aunt with breast cancer – age 65 Paternal grandmother with breast cancer – age 79 Alison has no other risk factors for breast cancer. Menses began at age 11. 1st child at age 25. She feels that with her family history, breast cancer is inevitable
Slide 35-

Case 2: Pedigree Dx 58 65 yr Dx 65 71 yr Dx 79 d.81 Caucasian mix Swedish / Finnish Key: -Breast CA Alison 40 yr 15 yr
Slide 36-

Case 2: Risk Assessment Gail Model: 5 year risk of 1.2% / lifetime risk of 20.4% Claus Model: Lifetime risk of 18.8% Myriad table: 3.4% risk of BRCA1/2 mutation using family history Pedigree analysis: no indications of other breast cancer syndromes Patient concerns
Slide 37-

“Moderate/Familial” Risk Clustering of cancer cases seen in the family Ages of onset not strikingly young Risks for first degree relatives increased Risk depends on number of family members affected, how closely related, ages of onset Multiple low-power genes may play a role and interact with environmental triggers
Slide 38-

Case 2: Pedigree Dx 58 65 yr Dx 65 71 yr Dx 79 d.81 Caucasian mix Swedish / Finnish Key: -Breast CA Alison 40 yr
Slide 39-

Risk Based Management Moderate/Familial: BSE monthly; CBE once or twice a year Mammogram once a year starting at 35 or 5-10 yrs prior to earliest case of breast cancer Immediate biopsy of any suspicious findings Option: Chemoprevention Lifestyle changes
Slide 40-

Case 2: Assessment Patient is in “Moderate/Familial” risk category Can begin breast cancer screening by age 35 Counseling issues: Low risk for BRCA1 or BRCA2 mutation Screening and preventive strategies Psychosocial – perceived risk, fears Support resources Referral to genetics if patient anxiety remains high or other questions arise
Slide 41-

Preventive lifestyle measures Increase exercise – 30 min. or more most days Weight control Diet ?? (results inconclusive): Less saturated, animal and trans fat, more fish Less refined flour, sugar More fruits/vegetables, whole grains, beans, nuts More fiber, antioxidant supplements?? (data limited) Alcohol: less than 1-2 drinks/day Breast feeding
Slide 42-

Oregon Genetics Providers Portland Oregon Health & Science University Legacy Health Care Northwest Perinatal Services Kaiser-Permanente Eugene Center for Genetics & Maternal Fetal Medicine Bend Genetic Counseling of Central Oregon (cancer only)
Slide 43-

Genetic Services Information Consult “Genetic Services contact list” Phone consultations available: OHSU Genetics Consultation Line 503-494-5516 Refer patients by phone, fax, mail, or patient self-referral ‘Indications For Referral’ in resource packet Preconception/prenatal Pediatric Adolescent/Adult
Slide 44-

Resource Materials Pedigree symbols and template Patient pamphlets: ‘Do You Have Cancer in Your Family?’ ‘Genetic Testing: A Fact Sheet’ Web-based cancer genetics resource list Resource materials at www.healthoregon.org/genetics Genetics tutorials on www.modimes.org